Free-cash-flow proxy decreased 98.8%
Free-cash-flow proxy changed -98.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed -98.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capital expenditure changed +176.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash flow changed -98.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +1560 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed -45200 basis points from the comparable as-filed period.
Operating income changed -31.7% from the comparable as-filed period.
Research & development changed +57.8% from the comparable as-filed period.
Cost of revenue changed -57.7% from the comparable as-filed period.
Shares outstanding changed +35.9% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Cash & equivalents changed -24.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -10.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
SBC / revenue changed -834 basis points from the comparable as-filed period.
Capex / revenue changed +238 basis points from the comparable as-filed period.
Revenue changed -8.3% from the comparable as-filed period.
Free-cash-flow margin changed -65838 basis points from the comparable as-filed period.
Operating cash-flow margin changed -65600 basis points from the comparable as-filed period.
R&D / revenue changed +46474 basis points from the comparable as-filed period.
Current assets changed -6.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital / assets changed -221 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -12.8% from the comparable as-filed period.
Current liabilities changed +5.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed -5.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed -10.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.